Annual Cash & Cash Equivalents
$36.96 M
+$6.78 M+22.45%
December 31, 2023
Summary
- As of February 26, 2025, BVS annual cash & cash equivalents is $36.96 million, with the most recent change of +$6.78 million (+22.45%) on December 31, 2023.
- During the last 3 years, BVS annual cash & cash equivalents has fallen by -$49.88 million (-57.43%).
- BVS annual cash & cash equivalents is now -57.43% below its all-time high of $86.84 million, reached on December 31, 2020.
Performance
BVS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$43.07 M
+$11.08 M+34.63%
September 28, 2024
Summary
- As of February 26, 2025, BVS quarterly cash and cash equivalents is $43.07 million, with the most recent change of +$11.08 million (+34.63%) on September 28, 2024.
- Over the past year, BVS quarterly cash and cash equivalents has increased by +$6.11 million (+16.53%).
- BVS quarterly cash and cash equivalents is now -68.34% below its all-time high of $136.06 million, reached on June 1, 2021.
Performance
BVS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BVS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.4% | +16.5% |
| 3 y3 years | -57.4% | -2.0% |
| 5 y5 years | -13.6% | -2.0% |
BVS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.9% | +22.4% | -8.6% | +71.1% |
| 5 y | 5-year | -57.4% | +22.4% | -68.3% | +71.1% |
| alltime | all time | -57.4% | +646.8% | -68.3% | +598.6% |
Bioventus Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.07 M(+34.6%) |
| Jun 2024 | - | $31.99 M(+27.1%) |
| Mar 2024 | - | $25.17 M(-31.9%) |
| Dec 2023 | $36.96 M(+22.5%) | $36.96 M(+37.8%) |
| Sep 2023 | - | $26.83 M(-8.7%) |
| Jun 2023 | - | $29.39 M(-37.6%) |
| Mar 2023 | - | $47.10 M(+56.0%) |
| Dec 2022 | $30.19 M(-31.3%) | $30.19 M(-12.1%) |
| Sep 2022 | - | $34.36 M(-16.2%) |
| Jun 2022 | - | $41.00 M(+49.8%) |
| Mar 2022 | - | $27.37 M(-37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $43.93 M(-49.4%) | $43.93 M(-45.7%) |
| Sep 2021 | - | $80.92 M(-40.5%) |
| Jun 2021 | - | $136.06 M(+9.5%) |
| Mar 2021 | - | $124.25 M(+43.1%) |
| Dec 2020 | $86.84 M(+34.6%) | $86.84 M(+19.8%) |
| Sep 2020 | - | $72.48 M(+12.3%) |
| Dec 2019 | $64.52 M(+50.8%) | $64.52 M(+946.4%) |
| Dec 2018 | $42.77 M(+764.1%) | - |
| Mar 2016 | - | $6.17 M |
| Dec 2015 | $4.95 M(-68.6%) | - |
| Dec 2014 | $15.77 M | - |
FAQ
- What is Bioventus annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bioventus?
- What is Bioventus annual cash & cash equivalents year-on-year change?
- What is Bioventus quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bioventus?
- What is Bioventus quarterly cash and cash equivalents year-on-year change?
What is Bioventus annual cash & cash equivalents?
The current annual cash & cash equivalents of BVS is $36.96 M
What is the all time high annual cash & cash equivalents for Bioventus?
Bioventus all-time high annual cash & cash equivalents is $86.84 M
What is Bioventus annual cash & cash equivalents year-on-year change?
Over the past year, BVS annual cash & cash equivalents has changed by +$6.78 M (+22.45%)
What is Bioventus quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BVS is $43.07 M
What is the all time high quarterly cash and cash equivalents for Bioventus?
Bioventus all-time high quarterly cash and cash equivalents is $136.06 M
What is Bioventus quarterly cash and cash equivalents year-on-year change?
Over the past year, BVS quarterly cash and cash equivalents has changed by +$6.11 M (+16.53%)